Markets Rise on Strong Earnings and Tame Inflation Despite Tariff Concerns
U.S. stocks ended the week higher as positive earnings and lower-than-expected inflation data outweighed concerns about new tariffs. The Federal Reserve is expected to keep rates steady at its upcoming meeting.
U.S. equity markets posted gains for the week, supported by robust corporate earnings and lower-than-anticipated inflation figures, even as new tariff discussions introduced some uncertainty. The S&P 500 advanced 0.59%, led by technology, utilities, and industrial sectors, while the Nasdaq climbed 1.51%. The Dow Jones Industrial Average edged down 0.07% after a report indicated President Donald Trump was seeking 15% to 20% tariffs in negotiations with the European Union.
The June consumer price index (CPI) met expectations, rising 2.7% year over year, while the core CPI, which excludes food and energy, increased 2.9%, slightly below forecasts. Shelter costs rose 3.8% from a year earlier, remaining above the overall inflation rate but showing signs of moderation. The Federal Reserve faces the challenge of balancing inflation control with maintaining low unemployment, which stood at 4.1% in June. Initial jobless claims have declined for five consecutive weeks, and the market anticipates the Fed will hold its benchmark rate steady at its late July meeting, with possible rate cuts later in the year.
Producer price index (PPI) data for June also came in below expectations, suggesting subdued wholesale inflation. While some tariff-sensitive goods categories saw price increases above the headline CPI, the overall impact of tariffs on consumer prices has so far been limited. Analysts note that the effects could become more pronounced over time.
Other economic indicators were positive, including stronger-than-expected industrial production, capacity utilization, retail sales, and housing starts for June. Corporate earnings reports were generally favorable. Wells Fargo shares rebounded after an initial drop following its earnings report, as investors focused on the company’s shift toward more predictable fee-based revenue. BlackRock’s stock also recovered after a revenue miss, with analysts highlighting organic growth in fee revenue and the recent acquisition of private credit manager HPS. Goldman Sachs reported strong results, supported by high capital levels and an improving environment for IPOs and mergers. Abbott Laboratories exceeded earnings expectations but saw its shares fall after management lowered its outlook; the stock partially recovered following analyst upgrades.
Market participants continue to monitor inflation, tariffs, and Federal Reserve policy as key factors influencing the economic outlook.
Source
CNBCRelated News
Fact-checking
Fact-check the facts of the article using external sources and databases.